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journal homepage: http: / /www.kjms-onl ine.comLETTER TO THE EDITORDiffuse large B-cell lymphoma presenting with
type B lactic acidosis and hemophagocytic
syndromeTo the Editor,
We report the case of a 51-year-old woman who was diag-
nosed with diffuse large B cell lymphoma presenting with
hemophagocytic syndrome complicated by type B lactic
acidosis. The patient came to our hospital because of an
intermittent fever for 1 week. The initial laboratory findings
revealed the following: white blood cell count, 3600/mL;
hemoglobin, 10.1 g/dL; platelet, 28,000/mL. Her serum C-
reactive protein level was 47.7 mg/L, and arterial blood gas
analysis showed pH 7.28, PCO2 38.1 mmHg, and HCO3 17.6 m
mol/L. Her lactate level was 11.8mEq/L, sodium 135mg/dL,
and chloride 104 mg/dL. A high anion gap metabolic acidosis
related to lactic acidosis was noted. She had a pulse rate of
95 beats/minute, and her blood pressure was 130/75 mmHg.
The bone marrow examination revealed hemophagocy-
tosis (Fig. 1A). The patient’s computed tomography scan
revealed a right adrenal gland tumor of about 6.8 cm and a
liver nodule of about 4.7 cm in S6eS7 (Fig. 1B). A liver
nodular biopsy revealed diffuse, large lymphoid cells con-
taining coarse chromatin and scant-to-moderate cytoplasm
(Fig. 1C), and the immunohistochemical analysis revealed
that the neoplastic cells were positive for CD20 (Fig. 1D),
Bcl-2, and Ki-67 (data not shown), but negative for CD3.
The final diagnosis was diffuse large B-cell lymphoma
complicated by type B lactic acidosis and hemophagocytic
syndrome. Positron emission tomography revealed
increased fluorodeoxyglucose avidity over the pelvic, liver,
bilateral adrenal gland, shoulder, and right neck areas
(data not shown).
The patient was then treated with a systemic chemo-
therapy consisting of EPOCH (etoposide, epirubicin,
vincristine, cyclophosphamide, and prednisolone). Because1607-551X/$36 Copyright ª 2013, Kaohsiung Medical University. Publish
http://dx.doi.org/10.1016/j.kjms.2013.10.001the patient suffered from dyspnea after undergoing
chemotherapy, we checked her arterial blood gas analysis;
the results showed deterioration, with pH 7.18, PCO2 29.3 y
values were as follows: lactate level 18.3 mEq/L, uric acid
7.2 mg/dL, potassium 6.1 mmol/L, and phosphate 7.1 mg/
dL. The patient was diagnosed to have lactic acidosis with
respiratory decompensation and tumor lysis syndrome.
Chemotherapy was discontinued, and a pulse therapy of
methylprednisolone (500 mg) was given every 12 hours for 3
days. After the pulse therapy, her lactate level decreased
to 2.6 mEq/L, and her metabolic acidosis and general
condition improved gradually.
The cause of the development of type B lactic acidosis in
hematological malignancies is likely multifactorial. Blood
glucose may be converted one step beyond pyruvate to
lactic acid even with abundant oxygen by tumor cells [1].
Severe liver or kidney dysfunction may reduce the hepatic
utilization of lactate via gluconeogenesis and lead to
lactate accumulation [2]. The mechanism was also possible
because of the loss of mitochondrial function [3].
The association of hemophagocytic syndrome with B-cell
non-Hodgkin’s lymphoma remains unclear. Lymphoma-
associated hemophagocytosis develops rapidly and is fatal
within several months of onset [4]. However, it is not an
unfavorable prognostic factor for large B-cell lymphoma.
The principal treatment is immune suppression to reduce
the cytokine storm [5].
To the best of our knowledge, this is the first study to
report this type of clinical findings. Type B lactic acidosis
should be considered in patients with hematologic disease
and clinical findings of dyspnea with high anion gap meta-
bolic acidosis and stable vital signs but no specific chest X-
ray findings.ed by Elsevier Taiwan LLC. All rights reserved.
Figure 1. (A) Activated macrophage with phagocyted platelets and red blood cells in the cytoplasm (original magnification,
1000). (B) Abdominal computed tomography revealed a 6.8-cm right adrenal gland tumor and a 4.7-cm liver nodule in S6eS7
(arrows). (C) Liver nodular biopsy revealed diffuse, large-sized lymphoid cells containing coarse chromatin and scant-to-moderate
cytoplasm (original magnification, 400). (D) Positive immunohistochemical staining for CD20 of neoplastic cells (original magni-
fication, 400).
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